Literature DB >> 30209094

Optimizing medications in older adults with cognitive impairment: Considerations for primary care clinicians.

Linda Lee1, Tejal Patel2, Frank Molnar3, Dallas Seitz4.   

Abstract

OBJECTIVE: To provide primary care physicians with an approach to medication optimization in older adults with cognitive impairment. SOURCES OF INFORMATION: The approach is based on an accredited memory clinic training program developed by the Centre for Family Medicine Primary Care Collaborative Memory Clinic. MAIN MESSAGE: Dementia increases the risk of medication-related adverse events and adds to the complexity and challenge of providing optimal care for these older adults. Considerations include medication adherence, appropriate therapeutic targets for comorbid conditions, minimized use of medications with potentially adverse cognitive effects, and rational use and monitoring of cognition-enhancing drugs. Medication management plans must be individualized and based on goals of care.
CONCLUSION: Primary care physicians must consider many factors in optimizing medications for those with cognitive impairment. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Year:  2018        PMID: 30209094      PMCID: PMC6135130     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  79 in total

1.  Association between blood pressure and cognitive function in a biracial community population of older persons.

Authors:  Martha Clare Morris; Paul A Scherr; Liesi E Hebert; David A Bennett; Robert S Wilson; Robert J Glynn; Denis A Evans
Journal:  Neuroepidemiology       Date:  2002 May-Jun       Impact factor: 3.282

2.  Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.

Authors:  Cheryl L P Vigen; Wendy J Mack; Richard S E Keefe; Mary Sano; David L Sultzer; T Scott Stroup; Karen S Dagerman; John K Hsiao; Barry D Lebowitz; Constantine G Lyketsos; Pierre N Tariot; Ling Zheng; Lon S Schneider
Journal:  Am J Psychiatry       Date:  2011-05-15       Impact factor: 18.112

3.  National surveillance of emergency department visits for outpatient adverse drug events.

Authors:  Daniel S Budnitz; Daniel A Pollock; Kelly N Weidenbach; Aaron B Mendelsohn; Thomas J Schroeder; Joseph L Annest
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

4.  The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.

Authors:  Victor I Reus; Laura J Fochtmann; A Evan Eyler; Donald M Hilty; Marcela Horvitz-Lennon; Michael D Jibson; Oscar L Lopez; Jane Mahoney; Jagoda Pasic; Zaldy S Tan; Cheryl D Wills; Richard Rhoads; Joel Yager
Journal:  Am J Psychiatry       Date:  2016-05-01       Impact factor: 18.112

5.  Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS).

Authors:  John Gallacher; Peter Elwood; Janet Pickering; Antony Bayer; Mark Fish; Yoav Ben-Shlomo
Journal:  J Epidemiol Community Health       Date:  2011-10-27       Impact factor: 3.710

6.  The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent?

Authors:  E J M Bierman; H C Comijs; C M Gundy; C Sonnenberg; C Jonker; A T F Beekman
Journal:  Int J Geriatr Psychiatry       Date:  2007-12       Impact factor: 3.485

7.  Mental health-related drug utilization among older adults: prevalence, trends, and costs.

Authors:  Muhammad Mamdani; Mark Rapoport; Kenneth I Shulman; Nathan Herrmann; Paula A Rochon
Journal:  Am J Geriatr Psychiatry       Date:  2005-10       Impact factor: 4.105

Review 8.  A scoping review on medication adherence in older patients with cognitive impairment or dementia.

Authors:  Zain K Hudani; Carlos H Rojas-Fernandez
Journal:  Res Social Adm Pharm       Date:  2015-12-02

9.  Association between Benzodiazepine Use and Dementia: A Meta-Analysis.

Authors:  GuoChao Zhong; Yi Wang; Yong Zhang; Yong Zhao
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

Review 10.  Identifying and Managing Pain in People with Alzheimer's Disease and Other Types of Dementia: A Systematic Review.

Authors:  Bettina S Husebo; Wilco Achterberg; Elisabeth Flo
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

View more
  3 in total

1.  The term cognition-enhancing medications is misleading.

Authors:  Joel R Lexchin
Journal:  Can Fam Physician       Date:  2018-11       Impact factor: 3.275

2.  Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.

Authors:  Liang-Yu Chen; Huey-Juan Lin; Wen-Tung Wu; Yong-Chen Chen; Cheng-Li Chen; Jing Kao; San-Lin You; Yu-Ching Chou; Chien-An Sun
Journal:  Int J Environ Res Public Health       Date:  2020-11-09       Impact factor: 3.390

Review 3.  A systematic review of interventions to reduce anticholinergic burden in older people with dementia in primary care.

Authors:  Bara'a Shawaqfeh; Carmel M Hughes; Bernadette McGuinness; Heather E Barry
Journal:  Int J Geriatr Psychiatry       Date:  2022-04-27       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.